Building the Future of Drug Discovery
A focused team of experts at the intersection of AI, computational science, and drug discovery.
Dr. Valentin Zhigulin
Founder & Chief Scientific Officer
Dr. Zhigulin is a pioneering computational scientist with 20+ years of experience applying deep learning and machine learning to complex scientific challenges. He holds a Ph.D. in Physics and Computational Neuroscience from the California Institute of Technology, and completed his postdoctoral research in Computational Neuroscience and Machine Learning at MIT.
A founding member of the Connectome project in 2004, Dr. Zhigulin was among the first researchers to apply Convolutional Neural Networks to neuroscience—well before deep learning entered the mainstream. His career spans computational neuroscience, quantitative biology, advanced machine learning, and financial engineering, consistently pushing the boundaries at the intersection of cutting-edge AI and complex scientific problems.
At Axia Discovery, he is leveraging this unique expertise to transform early-stage drug discovery through computational peptide design, in-silico screening, and AI-driven optimization.
Education
- • Ph.D., Physics & Computational Neuroscience — California Institute of Technology
- • Postdoctoral Fellow, Computational Neuroscience & Machine Learning — Massachusetts Institute of Technology
We're Growing
We are building a world-class team of computational scientists, machine learning engineers, and structural biologists. If you're passionate about AI-driven drug discovery, we'd love to hear from you.
Get in TouchReady to accelerate your drug discovery program?
Whether you're seeking a computational co-development partner, licensing opportunities, or looking to advance a difficult target — let's talk.